Citation Impact
Citing Papers
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
2015
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery
2010
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules
2013 Standout
Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
2014
A Non–Cancer-Related Survival Benefit Is Associated With Partial Nephrectomy
2011
Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
2015
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review
2016
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016
2016
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Risk model of in-hospital mortality after pulmonary resection for cancer: A national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor)
2010
Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal Cancer
2012
Current status and future directions of cancer immunotherapy
2018
Treatment of Stage I and II Non-small Cell Lung Cancer
2013
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder
2016
Cisplatin: The first metal based anticancer drug
2019 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients
2015
Implications of the tumor immune microenvironment for staging and therapeutics
2017
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
2020
Targeting immune cells for cancer therapy
2019
Renal cell carcinoma
2017 Standout
Decision Making in Patients with Pulmonary Nodules
2011
Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer—Do Outcomes Differ?
2017
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study
2016
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
2020
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
2013 Standout
Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications
2019
Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation
2013
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
Bladder Cancer
2020 Standout
Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis
2018
Quality of diagnostic staging in patients with bladder cancer: A process‐outcomes link
2014
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Works of Max Kates being referenced
Immune checkpoint inhibitors: a new frontier in bladder cancer
2015
Survival After Diagnosis of Localized T1a Kidney Cancer: Current Population-based Practice of Surgery and Nonsurgical Management
2013
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
2016
Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?
2012
Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy
2016
Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma
2017
Morbidity of Urologic Surgical Procedures: An Analysis of Rates, Risk Factors, and Outcomes
2015
Survival Following Lobectomy and Limited Resection for the Treatment of Stage I Non-small Cell Lung Cancer ≤ 1 cm in Size
2010
Validation of a Model to Predict Perioperative Mortality from Lung Cancer Resection in the Elderly
2008
Secondary bladder cancer after upper tract urothelial carcinoma in the US population
2012
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis
2012
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
2019
Increased Risk of Overall and Cardiovascular Mortality After Radical Nephrectomy for Renal Cell Carcinoma 2 cm or Less
2011
Comorbidities and causes of death in the management of localized T 1a kidney cancer
2014
Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference
2016